Sublingual Immunotherapy Market
Sublingual Immunotherapy Market Scope: Industry
Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Sublingual Immunotherapy Market Size and Growth
The Sublingual Immunotherapy market is experiencing robust growth, driven by rising allergic disorders and increased patient preference for non-invasive treatments. The global market size is projected to reach approximately $3.2 billion by 2026, indicating significant opportunities for stakeholders amidst evolving regulatory landscapes and advancements in therapeutic formulations.
Companies Covered
(Covid 19 Impact Covered)
◍ Anergis
◍ HAL Allergy Group
◍ Merck
◍ Allergy Therapeutics
◍ ALK-Abello
◍ Stallergenes Greer
◍ Laboratorios LETI
The sublingual immunotherapy market is competitive, with companies like Anergis, HAL Allergy Group, Merck, Allergy Therapeutics, ALK-Abello, Stallergenes Greer, and Laboratorios LETI driving growth through innovative therapies, strategic partnerships, and expanding product portfolios. Key revenue figures include:
- Merck: $1 billion (global allergy segment)
- ALK-Abello: €800 million
- Allergy Therapeutics: £50 million
Request Sample Report
Market Segmentation
By Application
◍ Retail Pharmacies
By Product
◍ Asthma
Food Allergy ◍ Hospital Pharmacies ◍ Online Pharmacies
Allergic Rhinitis
Venom Allergy
Request Sample Report
Market Growth
Request Sample Report
$ 2.96 Billion
